Filter by: patients
Home > Community Treatment Reports and Side Effects > Apidra Insulin Glulisine Treatment Report
What is Apidra Insulin Glulisine?

Apidra is a brand name for insulin glulisine a rapid acting insulin used in the treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) to improve glycemic control.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 1 6 0
Diabetes Type 2 4 1 Efficacy_major
hard to control blood sugars 1 0
General health 1 0
Other 1 0

See all 12 patients currently taking Apidra Insulin Glulisine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  4 100units/mL as needed 30ml as needed 100units/mL as needed 3 100units/mL as needed 100 units daily 150 units daily 2,800 units daily 10,000 units daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Apidra Insulin Glulisine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 100%

See all 1 patient who’ve stopped taking Apidra Insulin Glulisine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Apidra Insulin Glulisine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Apidra Insulin Glulisine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Apidra Insulin Glulisine

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Apidra Insulin Glulisine

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Apidra Insulin Glulisine

$200+
 1 100%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.